Japan, Oct. 29 -- TAKEDA PHARMACEUTICALS U S A INC has got intellectual property rights for 'GLP-2 ANALOGS AND GLP-2 PEPTIBODIES FOR ADMINISTRATION BEFORE, DURING OR AFTER SURGERY.' Other related details are as follows:

Application Number: JP,2023-096692

Category (FI): A61K38/26,A61P1/00,A61P1/14,C07K14/575,C07K14/605

Stage: Grant(IP right document published.)

Filing Date: June 13, 2023

Publication Date: Aug. 3, 2023

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....